Abstract
Esophageal resection is a key component of the multidisciplinary management of esophageal cancer. Robotic-assisted minimally invasive esophagectomy is gaining widespread approval amongst few centers with promising early data. There is significant variability in the operative approach utilized by different centers and this review describes, step-by-step, the operative technique at a high-volume tertiary center. The cornerstone of management is individualized surgical approach, based on patient, tumor and technical factors. Although our approach is based on aforementioned factors, our preferred approach is an Ivor Lewis esophagectomy and this review focuses on that. The procedure is broken down into three key parts, starting with an abdominal exploration and creation of the gastric conduit, placement of jejunostomy tube, moving to thoracic mobilization and creation of the side-side 6 cm stapled esophagogastric anastomosis with a final abdominal portion to assure proper positioning of the conduit and reducing redundancy. This approach is fully robotic and a side to side anastomosis facilitates the creation of a widely patent anastomosis therefore minimizing the risk of anastomotic leaks and strictures. Our experience with minimally invasive esophagectomy, as has been previously published, is associated with a 5.1% of anastomotic leak and 7.6% of anastomotic stricture. The robotic platform further optimizes this technique and helps us safely accomplish a side to side stapled anastomosis. Superior instrument dexterity in a restricted thoracic space is facilitated by intracorporeal suturing and robotic stapling. Thus, it obviates the need for a larger thoracotomy incision, which is typically needed for an EEA anastomosis, and that is traditionally associated with higher stricture rate.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13304-021-01000-y/MediaObjects/13304_2021_1000_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13304-021-01000-y/MediaObjects/13304_2021_1000_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13304-021-01000-y/MediaObjects/13304_2021_1000_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13304-021-01000-y/MediaObjects/13304_2021_1000_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13304-021-01000-y/MediaObjects/13304_2021_1000_Fig5_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13304-021-01000-y/MediaObjects/13304_2021_1000_Fig6_HTML.jpg)
Similar content being viewed by others
Data availability
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
References
Pohl H, Sirovich B, Welch HG (2010) Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomark Prev 19(6):1468–1470
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
National Comprehensive Cancer Network (2020) Esophageal and esophagogastric junction cancers (Version 1.2020). http://www.nccn.org/professionals/physician_gls/pdf/esopjageal.pdf. Accessed 26 Apr 2020
Biere SSAY, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379(9829):1887–1892
Straatman J, van der Wielen N, Cuesta MA, Daams F, Roig Garcia J, Bonavina L et al (2017) Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME Trial. Ann Surg 266(2):232–236
Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D et al (2019) Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med 380(2):152–162
Luketich JD, Pennathur A, Franchetti Y, Catalano PJ, Swanson S, Sugarbaker DJ et al (2015) Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg 261(4):702–707
Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M et al (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103
Ben-David K, Tuttle R, Kukar M, Rossidis G, Hochwald SN (2016) Minimally invasive esophagectomy utilizing a stapled side-to-side anastomosis is safe in the western patient population. Ann Surg Oncol 23(9):3056–3062
Seto Y, Mori K, Aikou S (2017) Robotic surgery for esophageal cancer: merits and demerits. Ann Gastroenterol Surg 1(3):193–198
van Hillegersberg R, Boone J, Draaisma WA, Broeders IA, Giezeman MJ, Borel Rinkes IH (2006) First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 20(9):1435–1439
van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA et al (2019) Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 269(4):621–630
Peng JS, Kukar M, Hochwald SN (2020) Technique for robotic transhiatal esophagectomy. Ann Surg Oncol. https://doi.org/10.1245/s10434-019-08186-x
Peng JS, Nurkin SJ, Hochwald SN, Kukar M (2020) Technique for robotic Ivor Lewis esophagectomy with 6-cm linear stapled side-to-side anastomosis. Ann Surg Oncol 27(3):824
van Hagen PHM, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084
Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16(9):1090–1098
Alderson D, Cunningham D, Nankivell M, Blazeby JM, Griffin SM, Crellin A et al (2017) Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Lancet Oncol 18(9):1249–1260
Haverkamp L, Seesing MF, Ruurda JP, Boone J, Hillegersberg RV (2017) Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus 30(1):1–7
Kukar M, Ben-David K, Peng JS et al (2019) Minimally invasive Ivor Lewis esophagectomy with linear stapled anastomosis associated with low leak and stricture rates. J Gastrointest Surg. https://doi.org/10.1007/s11605-019-04320-y
Singh D, Maley RH, Santucci T et al (2001) Experience and technique of stapled mechanical cervical esophagogastric anastomosis. Ann Thorac Surg 71:419–424
Orringer MB, Marshall B, Iannettoni MD (2000) Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 119:277–288
Ercan S, Rice TW, Murthy SC, Rybicki LA, Blackstone EH (2005) Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg 129(3):623–631
Liu QX, Min JX, Deng XF, Dai JG (2014) Is hand sewing comparable with stapling for anastomotic leakage after esophagectomy? A meta-analysis. World J Gastroenterol 20(45):17218–17226
Deng XF, Liu QX, Zhou D, Min JX, Dai JG (2015) Hand-sewn vs linearly stapled esophagogastric anastomosis for esophageal cancer: a meta-analysis. World J Gastroenterol 21(15):4757–4764
van der Sluis PC, Tagkalos E, Hadzijusufovic E et al (2020) Robot-assisted minimally invasive esophagectomy with intrathoracic anastomosis (Ivor Lewis): promising results in 100 consecutive patients (the european experience). J Gastrointest Surg. https://doi.org/10.1007/s11605-019-04510-8
Okusanya OT, Sarkaria IS, Hess NR, Nason KS, Sanchez MV, Levy RM et al (2017) Robotic assisted minimally invasive esophagectomy (RAMIE): the University of Pittsburgh Medical Center initial experience. Ann Cardiothorac Surg 6(2):179–185
Sarkaria IS, Rizk NP, Grosser R, Goldman D, Finley DJ, Ghanie A et al (2016) Attaining proficiency in robotic-assisted minimally invasive esophagectomy while maximizing safety during procedure development. Innov (Phila) 11(4):268–273
Yang Y, Zhang X, Li B, Li Z, Sun Y, Mao T et al (2019) Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy). BMC Cancer 19(1):608
Chao YK, Li ZG, Wen YW, Kim DJ, Park SY, Chang YL et al (2019) Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy (REVATE): study protocol for a randomized controlled trial. Trials 20(1):346
Zhang Y, Han Y, Gan Q, **ang J, ** R, Chen K et al (2019) Early outcomes of robot-assisted versus thoracoscopic-assisted Ivor Lewis esophagectomy for esophageal cancer: a propensity score-matched study. Ann Surg Oncol 26(5):1284–1291
Funding
National Cancer Institute Roswell Park Cancer Institute Support Grant award number P30CA016056.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Research involving human participants and/or animals
After IRB approval the data was retrospectively reviewed.
Conflict of interest
Nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chouliaras, K., Hochwald, S. & Kukar, M. Robotic-assisted Ivor Lewis esophagectomy, a review of the technique. Updates Surg 73, 831–838 (2021). https://doi.org/10.1007/s13304-021-01000-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-021-01000-y